1. Home
  2. CSAN vs ICUI Comparison

CSAN vs ICUI Comparison

Compare CSAN & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cosan S.A. ADS

CSAN

Cosan S.A. ADS

HOLD

Current Price

$3.00

Market Cap

3.0B

ML Signal

HOLD

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$157.44

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSAN
ICUI
Founded
1936
1984
Country
Brazil
United States
Employees
N/A
N/A
Industry
Retail-Auto Dealers and Gas Stations
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.6B
IPO Year
2008
1995

Fundamental Metrics

Financial Performance
Metric
CSAN
ICUI
Price
$3.00
$157.44
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
$4.75
$169.00
AVG Volume (30 Days)
995.8K
269.5K
Earning Date
05-15-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
100.62
EPS
N/A
1.20
Revenue
N/A
$2,231,262,000.00
Revenue This Year
$321.51
N/A
Revenue Next Year
$3.57
$4.46
P/E Ratio
N/A
$127.88
Revenue Growth
N/A
N/A
52 Week Low
$2.52
$107.02
52 Week High
$6.01
$162.85

Technical Indicators

Market Signals
Indicator
CSAN
ICUI
Relative Strength Index (RSI) 49.46 58.75
Support Level $2.71 $139.88
Resistance Level $3.19 $161.30
Average True Range (ATR) 0.09 4.89
MACD 0.02 -0.64
Stochastic Oscillator 31.38 66.11

Price Performance

Historical Comparison
CSAN
ICUI

About CSAN Cosan S.A. ADS

Cosan SA engages in several services throughout the energy and logistics sectors. Its reportable segments are Raizen, Compass, Moove, Rumo, and Radar. It generates the majority of its revenue from Raizen which operates in the production, commercialization, origination, and trading of ethanol, bioenergy, resale, and trading of electricity, renewable sources, marketing, origination, and trading of sugar and fuels, and lubricant.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: